Fourier Health vs ThetaRho (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Both turn scattered records into something usable and they place the human in different places. Fourier ingests the mess directly, faxes, handwritten notes, exchange retrieved records, and produces summaries shaped to a specific use case, with every statement attributed to its source and a clinician network reviewing the output. ThetaRho separates the problem into layers and sells any of them, normalising from named record systems and exchanges, then answering clinical questions grounded in the patient's own record. The thing to interrogate on Fourier is that review network: it is the best oversight feature on the record and also its biggest privacy exposure, because real people are reading patient records from customer organisations and no contracting terms governing that chain were located. Ask who they are and what they may keep.

The case for Fourier Health
  • Every summarised statement is attributed to its source, and a clinician network reviews output, which combines two controls most competitors have only one of.
  • Summaries are shaped to the use case rather than produced in one general format, which is the more useful property when the reader is doing a specific job.
  • It ingests the messy reality, including faxes, handwritten notes and records retrieved from exchanges, rather than assuming structured input.
The case for ThetaRho
  • The layers are separable, so an organisation with clean data can buy only the intelligence, and one drowning in raw feeds can buy only the normalisation.
  • It names both the record systems it normalises from and the models it runs on, which is more supply chain disclosure than most of this category offers.
  • Verification is designed in at the answer level, with clinical question answering grounded in the patient's own record rather than in general knowledge.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Fourier Health and ThetaRho are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Fourier Health ThetaRho
Primary category Clinical Summarization & Chart Review Clinical Summarization & Chart Review
Founded 2023 Not recorded
Headquarters Miami, FL, US Not recorded
Website fourierhealth.com thetarho.ai
Attribute Matrix

Side by Side

Axis
F
Fourier Health
T
ThetaRho
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Fourier Health

The AI Health Index awards Fourier Health its top capability grade on AI Centrality. Set against ThetaRho, Fourier Health does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

ThetaRho

The AI Health Index awards ThetaRho its top capability grade on AI Centrality. Set against Fourier Health, ThetaRho grades higher on Model and Technology Transparency, Model Supply Chain Disclosure and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Fourier Health or ThetaRho?

The AI Health Index grades ThetaRho higher than Fourier Health on every axis that separates them, Model and Technology Transparency, Model Supply Chain Disclosure and HIPAA and BAA Posture. Fourier Health does not grade higher on any scored axis.

Where do Fourier Health and ThetaRho differ most?

The widest separation the AI Health Index records between Fourier Health and ThetaRho is on Model and Technology Transparency, where Fourier Health grades C and ThetaRho grades B. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do Fourier Health and ThetaRho grade the same?

The AI Health Index grades Fourier Health and ThetaRho the same on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.

Disclosure

Fourier's clinician review network is simultaneously its strongest oversight feature and its largest privacy exposure, since a network of reviewers sees patient records from customer organisations, and no compliance statement or business associate terms were located to govern that chain; establish who those reviewers are, how they are contracted and what they may retain. Neither vendor publishes a security attestation, retention position, training use statement or pricing. Neither publishes an omission rate, which is the decisive failure in summarisation because a summary that drops the one relevant record fails silently.